RecruitingNCT05950503
Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer
Single-center Ambispective Observational Study on the Role of Magnetic Resonance Imaging (MRI) in the Evaluation of Patient Affected by Hepatic Metastases of Carcinoma of the
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment
100 participants
Start Date
Jul 10, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.
Eligibility
Min Age: 18 YearsMax Age: 85 Years
Inclusion Criteria5
- Age \> 18 years;
- Histological diagnosis of colorectal cancer;
- Presence of liver metastases in the staging exams (chest-abdomen CT with contrast medium or PET-CT with 18-FDG);
- At least one measurable liver lesion according to RECIST 1.1 criteria;
- Adequate organ and marrow function.
Exclusion Criteria4
- Age \< 18 years;
- Inability to undergo MRI;
- Major contraindications to liver surgery;
- No written informed consent.
Interventions
RADIATIONHepatic MRI
The patients will undergo hepatic MRI in pre-established timepoints
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05950503
Related Trials
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
NCT0546403035 locations
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
NCT070717141 location
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
NCT0697316127 locations
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
NCT0624477126 locations
Camera Capsule Endoscopy in the Routine Diagnostic Pathway for Colorectal Diseases
NCT064755601 location